Home » Topics » BioWorld Science

BioWorld Science
RSS

Novel selective D3R ligands for the treatment of drug addiction

May 19, 2022

AFM-28 in combination with allogeneic NK cells as promising therapy for AML and MDS

May 19, 2022

U.S. researchers present preclinical data on KU-596 in X-linked Charcot-Marie-Tooth disease

May 19, 2022

New YAP1-TEAD interaction inhibitors identified at Vivace Therapeutics

May 19, 2022

TME Therapeutics discovers PIKfyve inhibitors

May 19, 2022

CXCR4-targeting compounds patented by the University of British Columbia, PHSA

May 19, 2022

New KRAS protein degraders synthesized at BioTheryX

May 19, 2022

Celgene, Zoetis describe new compounds for treating helminthic infections

May 19, 2022

DEPDC1-AS1 as novel biomarker for the early detection and prognosis of gastric cancer

May 19, 2022

AAV9-cTnT-GSLA01, a gene therapy to treat LMNA dilated cardiomyopathy

May 18, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 19, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...